MedPath

Treatment of burn scars using Ablative CO2 fractional Laser and topical rapamycin (sirolimus)

Not Applicable
Recruiting
Conditions
Burn NOS.
Burn of unspecified body region, unspecified degree
Registration Number
IRCT2016052318210N7
Lead Sponsor
Iran University of Medical Science
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

Inclusion criteria : All of patients with burn hypertrophic scar who will come to RasoulAkram hospital.
Exclusion criteria: 1. do not fill the consent inform 2. pregnancy or breast feeding women 3. psychological disorders that could not understand or fill consent inform

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Contracture. Timepoint: every months in treatment period and 6 months after treatment completion. Method of measurement: Imaging of skin and scoring with Vancouver scar scale.;Texture. Timepoint: every months in treatment period and 6 months after treatment completion. Method of measurement: Imaging of skin and scoring with Vancouver scar scale.
Secondary Outcome Measures
NameTimeMethod
Satisfaction. Timepoint: every months in treatment period and 6 months after treatment completion. Method of measurement: Interview.;Skin colour. Timepoint: every months in treatment period and 6 months after treatment completion. Method of measurement: Imaging of skin and scoring with Vancouver scar scale.;Atrophy. Timepoint: every months in treatment period and 6 months after treatment completion. Method of measurement: Imaging of skin and scoring with Vancouver scar scale.
© Copyright 2025. All Rights Reserved by MedPath